Comparative Pharmacology
Head-to-head clinical analysis: COR OTICIN versus SATRIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COR OTICIN versus SATRIC.
COR-OTICIN vs SATRIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
COR-OTICIN is a combination product containing hydrocortisone (a corticosteroid with anti-inflammatory and immunosuppressive properties) and neomycin (an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit) and polymyxin B (a polymyxin antibiotic that disrupts bacterial cell membrane permeability).
SATRIC is a combination of sulfathiazole, sulfacetamide, and sulfabenzamide, which are sulfonamide antibiotics. They competitively inhibit dihydropteroate synthase, blocking folate synthesis in susceptible bacteria.
1-2 drops in each affected ear twice daily for 7 days.
No standard dosing information available for SATRIC.
None Documented
None Documented
Terminal half-life 4-6 hours; prolonged in renal impairment (up to 12-15 hours)
3-5 hours in healthy adults; prolonged to 6-8 hours in renal impairment (CrCl < 30 mL/min)
Renal (60-80% unchanged), fecal/biliary (5-10%)
Renal: 70% unchanged; fecal: 20%; biliary: 10%
Category C
Category C
Topical Corticosteroid + Antibiotic
Antiprotozoal, Antibiotic